Michelle L. Basil

2019

In 2019, Michelle L. Basil earned a total compensation of $2.1M as Executive Vice President, General Counsel at Haemonetics, a 3% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$578,807
Option Awards$249,997
Salary$440,811
Stock Awards$862,844
Other$16,387
Total$2,148,846

Basil received $862.8K in stock awards, accounting for 40% of the total pay in 2019.

Basil also received $578.8K in non-equity incentive plan, $250K in option awards, $440.8K in salary and $16.4K in other compensation.

Rankings

In 2019, Michelle L. Basil's compensation ranked 5,556th out of 13,971 executives tracked by ExecPay. In other words, Basil earned more than 60.2% of executives.

ClassificationRankingPercentile
All
5,556
out of 13,971
60th
Division
Manufacturing
2,080
out of 5,701
64th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
282
out of 832
66th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
164
out of 535
69th
Industry
Surgical and Medical Instruments and Apparatus
98
out of 350
72nd

Pay ratio

Michelle L. Basil's Pay$2,148,846
Median Employee's Pay$41,811
Pay Ratio

51

to 1

In 2019, the annual total compensation of Michelle L. Basil was $2,148,846.

The annual total compensation of the median employee at Haemonetics was $41,811.

The ratio of Michelle L. Basil's pay to the pay of median employee was therefore 51 to one.

Source: SEC filing on June 12, 2019.

Basil's colleagues

We found four more compensation records of executives who worked with Michelle L. Basil at Haemonetics in 2019.

2019

Christopher Simon

Haemonetics

Chief Executive Officer

2019

William Burke

Haemonetics

Chief Financial Officer

2019

Jacqueline Scanlan

Haemonetics

Senior Vice President, Global Human Resources

2019

Said Bolorforosh

Haemonetics

Chief Technology Officer

News

You may also like